Abstract:
Various purine derivatives mainly 6 and 8-substituted sulfanylpurines were
synthesized and evaluated for their potential antithyroid activity. The basic theme of the
research work originated from the idea of combining the two most popular existing
antithyroid drugs, namely propylthiouracil (1) and methimazole (2), into a single
molecule to get the combined effect of both drugs through a single compound.
Interestingly it resulted in 2,8-disulfanyl-1,9-dihydro-6H-purin-6-one (86). The
compound was prepared using known method and three major series along with some
individual compounds were also synthesized because the structural properties of the
purines and their ability to complex with molecular iodine made them potential
antithyroid compounds. In this regard, a series of 8-(alkylsulfanyl)-3,9-dihydro-1H-
purine-2,6-diones (144-148) was synthesized using 8-sulfanyl-5,9-dihydro-1H-purine-
2,6-dione (84) and respective alkyl halides in aqueous solution; a second series of 6-
(Alkylsulfanyl)-9H-purines
(149-159)
was
synthesized
using
6-sulfanylpurine
monohydrate and respective alkyl halides in aqueous sodium hydroxide solution.
Similarly, ethyl (9H-purin-6-ylsulfanyl)acetate (162) was synthesized using 6-
sulfanylpurine monohydrate, triethylamine and ethyl chloroacetate in ethanol and 2-(9H-
purin-6-sulfanyl)acetohydrazide (163). Ethyl (9H-purin-6-sulfanyl)acetate (162) and
hydrazine hydrate were refluxed in ethanol to get the desired product. Both conventional
and microwave assisted methods were used. Microwave assisted heating reduced the
reaction time and improved the yield. A series of N'-[Substituted phenylmethylidene]-2-
(79-purin-6-sulfanyl)acetohydrazides (164-172) was also synthesized by heating 163 and
substituted benzaldehydes in ethanol under reflux.
The compounds were studied in vitro as well as in vivo for determining their
antithyroid effects. Fortunately, most of them showed significant antithyroid activity
with a few to be exceptionally good in this respect. The successful exposition of the
synthesized compounds endorsed the idea of the research programme. It is certainly not
the end but a new start. The 6 and 8 substituted purine derivatives may now be
categorized as a new class of antithyroid agents. These compounds can be used as
alternate drugs for popular benefit after completing the requisite procedures like
evaluation of cytotoxicity, determining metabolic route and clinical trial etc.